BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12960974)

  • 1. Widespread distribution of beta-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol.
    Bourgoin C; Emiliani C; Kremer EJ; Gelot A; Tancini B; Gravel RA; Drugan C; Orlacchio A; Poenaru L; Caillaud C
    Gene Ther; 2003 Oct; 10(21):1841-9. PubMed ID: 12960974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversion of the biochemical defects in murine embryonic Sandhoff neurons using a bicistronic lentiviral vector encoding hexosaminidase alpha and beta.
    Arfi A; Zisling R; Richard E; Batista L; Poenaru L; Futerman AH; Caillaud C
    J Neurochem; 2006 Mar; 96(6):1572-9. PubMed ID: 16441513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts.
    Arfi A; Bourgoin C; Basso L; Emiliani C; Tancini B; Chigorno V; Li YT; Orlacchio A; Poenaru L; Sonnino S; Caillaud C
    Neurobiol Dis; 2005 Nov; 20(2):583-93. PubMed ID: 15953731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced secretion of beta-hexosaminidase by human brain endothelial cells: a novel approach in Sandhoff disease?
    Batista L; Miller F; Clave C; Arfi A; Douillard-Guilloux G; Couraud PO; Caillaud C
    Neurobiol Dis; 2010 Mar; 37(3):656-60. PubMed ID: 20005954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic correction in microglia derived from Sandhoff disease model mice.
    Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Itoh K
    J Neurochem; 2005 Sep; 94(6):1631-8. PubMed ID: 16092933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer.
    Akli S; Guidotti JE; Vigne E; Perricaudet M; Sandhoff K; Kahn A; Poenaru L
    Gene Ther; 1996 Sep; 3(9):769-74. PubMed ID: 8875224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-hexosaminidase lentiviral vectors: transfer into the CNS via systemic administration.
    Kyrkanides S; Miller JH; Brouxhon SM; Olschowka JA; Federoff HJ
    Brain Res Mol Brain Res; 2005 Feb; 133(2):286-98. PubMed ID: 15710246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates.
    Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Kuwahara J; Yamanaka S; Itoh K
    J Neurochem; 2005 Mar; 92(6):1497-507. PubMed ID: 15748167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic hyperosmolality improves beta-glucuronidase distribution and pathology in murine MPS VII brain following intraventricular gene transfer.
    Ghodsi A; Stein C; Derksen T; Martins I; Anderson RD; Davidson BL
    Exp Neurol; 1999 Nov; 160(1):109-16. PubMed ID: 10630195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.
    Sango K; Yamanaka S; Hoffmann A; Okuda Y; Grinberg A; Westphal H; McDonald MP; Crawley JN; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1995 Oct; 11(2):170-6. PubMed ID: 7550345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and distribution of an Alu-type deletion mutation in Sandhoff disease.
    Neote K; McInnes B; Mahuran DJ; Gravel RA
    J Clin Invest; 1990 Nov; 86(5):1524-31. PubMed ID: 2147027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.
    Sango K; McDonald MP; Crawley JN; Mack ML; Tifft CJ; Skop E; Starr CM; Hoffmann A; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1996 Nov; 14(3):348-52. PubMed ID: 8896570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Gene Transfer of a Hexosaminidase Variant Using an scAAV9.47 Vector Corrects GM2 Gangliosidosis in Sandhoff Mice.
    Osmon KJ; Woodley E; Thompson P; Ong K; Karumuthil-Melethil S; Keimel JG; Mark BL; Mahuran D; Gray SJ; Walia JS
    Hum Gene Ther; 2016 Jul; 27(7):497-508. PubMed ID: 27199088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated virus-mediated expression of β-hexosaminidase prevents neuronal loss in the Sandhoff mouse brain.
    Sargeant TJ; Wang S; Bradley J; Smith NJ; Raha AA; McNair R; Ziegler RJ; Cheng SH; Cox TM; Cachón-González MB
    Hum Mol Genet; 2011 Nov; 20(22):4371-80. PubMed ID: 21852247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice.
    Itakura T; Kuroki A; Ishibashi Y; Tsuji D; Kawashita E; Higashine Y; Sakuraba H; Yamanaka S; Itoh K
    Biol Pharm Bull; 2006 Aug; 29(8):1564-9. PubMed ID: 16880605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipid synthesis is decreased in neuronal tissue in a mouse model of Sandhoff disease.
    Buccoliero R; Bodennec J; Van Echten-Deckert G; Sandhoff K; Futerman AH
    J Neurochem; 2004 Jul; 90(1):80-8. PubMed ID: 15198669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ assessment of beta-hexosaminidase activity.
    Lacorazza HD; Jendoubi M
    Biotechniques; 1995 Sep; 19(3):434-40. PubMed ID: 7495557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmid-based gene transfer ameliorates visceral storage in a mouse model of Sandhoff disease.
    Yamaguchi A; Katsuyama K; Suzuki K; Kosaka K; Aoki I; Yamanaka S
    J Mol Med (Berl); 2003 Mar; 81(3):185-93. PubMed ID: 12682727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsense mutation of feline beta-hexosaminidase beta-subunit (HEXB) gene causing Sandhoff disease in a family of Japanese domestic cats.
    Kanae Y; Endoh D; Yamato O; Hayashi D; Matsunaga S; Ogawa H; Maede Y; Hayashi M
    Res Vet Sci; 2007 Feb; 82(1):54-60. PubMed ID: 16872651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The trigeminal retrograde transfer pathway in the treatment of neurodegeneration.
    Kyrkanides S; Yang M; Tallents RH; Miller JN; Brouxhon SM; Olschowka JA
    J Neuroimmunol; 2009 Apr; 209(1-2):139-42. PubMed ID: 19278737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.